Skip to content

LIMAFRAN

Active Private limited companyfounded 2011active for 15 yearsRue Bénédicale 36, 4287 LincentKBO/BCE: BE 0835.109.622 #4 company by total assets in Lincent

Lifetime

15 annual accounts with figures on one time axis
peak of €675,587 in 2024
€556,638▼ 17.6%
lowest -€30,831 in 2013
€241,334▼ 21.8%
peak of €1.2m in 2024
€862,834▼ 26.5%
€1.1m▲ 53.8%
peak of 3.5 FTE in 2020
1.6 FTE▼ 36.0%
Board4 names since 2011
2 directors and 1 other
Documentsfilings and deeds
16-06-202645 days before the deadline
2025abbreviated format
Gross margin from €675,587 to €556,638Staff from 2.5 FTE to 1.6 FTEDividend €551,887Equity from €1.2m to €862,834Debts from €737,672 to €1.1mInvestments €105,339

Key points

from the 2025 annual accounts

Equity

€862,834 ▼ 26.5%
1.22024+0.2Profit-0.6Dividend0.92025

LIMAFRAN paid out €551,887 in dividends. That is 229% of the 2025 profit.

Debts

€1.1m ▲ 53.8%
Other debts
+0.5
Suppliers
+0.03
Advances received
+0.00
The rest
-0.09

Debts rose by €396,743 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€105,339 2.1 times depreciation
2021202220242025

Green is investment, beige is depreciation.

Staff

1 employees on 31-12-2025
212021432023232024122025

In 2025, 1 employee joined and 2 left.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Five of the last ten came late. The 2019 accounts came in latest, 59 days after the end of the period.

Board

2 joined

2 directors joined, the latest on 01-10-2026. 4 are in office now.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as LIMAFRAN has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for LIMAFRAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director
Director
  • 93 sharesdeed of 10-07-2024
  • 93 sharesdeed of 10-07-2024
Board & ownership

Recent changes

(director) and (director) appointed Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0835109622
(director) and (director) reappointed holds 93 shares · holds 93 shares · General meeting of 26-06-2024 · Gazette deed
appointed as manager General meeting of 31-12-2013 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
LIMAFRAN Lincent €2.0m €556,638 43.2% 1.6
LA ROCHE PHARMA La Roche-en-Ardenne €2.0m €536,756 43.2% 1.6
PHARMACIE CRUNENBERG-GILLET Stavelot €2.1m €553,685 29.8% 2.1
Pharmacie Loop Braine-le-Château €1.8m €527,058 40.3% 1.8
A.R.PHARMA Charleroi €2.1m €399,339 70.8% 1.6
APOTHEEK DAVID-COOLS Herk-de-Stad €2.1m €531,084 66.8% 1.1
Apotheek Cindy Nachtergaele Kruisem €2.2m €447,512 47.3% 1.7

These companies have the same main activity as LIMAFRAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.8m and €2.2m, founded between 2009 and 2014.

Official details

Source: KBO
Status
Active since 04-04-2011Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.197.735.8294367 Crisnée, since 04-04-2011
Financial year end
31 December
Peppol
Reachable since 12-09-2025
Company details

Annual accounts 2025

≈ €1.9mestimated
€2.0m▲ 4.5%
Employeeson 31-12-2025
1▼ 50.0%
Filing
Filed on 16-06-2026, 45 days before the end of the filing period
Financials

Insights on LIMAFRAN

LIMAFRAN files the abbreviated format. That format states no turnover. The gross margin rose from €152,832 in 2011 to €556,638 in 2025.

The balance sheet grew most from 2012 to 2013 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LIMAFRAN

What is the company number of LIMAFRAN?
The company number of LIMAFRAN is 0835.109.622. The VAT number is the same number with BE in front: BE 0835.109.622.
Where is LIMAFRAN based?
The registered office is at Rue Bénédicale 36, 4287 Lincent.Company details
What does LIMAFRAN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of LIMAFRAN?
LIMAFRAN is a private limited company (BV).
When was LIMAFRAN founded?
LIMAFRAN was founded on 04-04-2011.
Is LIMAFRAN still active?
Yes, LIMAFRAN is an active enterprise in the KBO register.
How many employees does LIMAFRAN have?
LIMAFRAN had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does LIMAFRAN fall under?
In its 2025 annual accounts, LIMAFRAN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of LIMAFRAN?
The turnover in financial year 2025 is about €1.9m. This figure is estimated from the gross margin of €556,638 and 42 comparable companies (NACE 477). It probably lies between €1.5m and €2.7m.
Is LIMAFRAN profitable?
In financial year 2025, LIMAFRAN made a profit of €241,334.
Where can I find the annual accounts of LIMAFRAN?
LIMAFRAN filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LIMAFRAN due?
LIMAFRAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.